SCIENTIFIC BACKGROUND

ALK, ATM, BRAF, BRCA1, BRCA2, CDKN2A, CHEK2, ERBB2, FBXW7, FGFR1, FGFR2, FGFR3, KRAS, MLH1, MSH2, MSH6, MYC, NTRK1, NTRK2, NTRK3, PALB2, PMS2, ROS1, SMAD4, STK11, TP53

Category:

Scientific Background

Pancreatic cancer is a type of cancer that originates from the cells of the pancreas. It is the 12th most common type of cancer worldwide. It is also characterized by high mortality rates and therefore it is considered the 3rd most common type of cancer. Cancer initiation and development are characterized by the accumulation of genetic mutations that cause the cancer cells to divide uncontrollably. Examples of genes that have been found to be mutated in patients with pancreatic cancer include KRAS, ALK, and BRCA1 among others. FDA/EMA approved drugs are available to target pancreatic cancer, depending on the molecular profile of the tumor and the mutated genes present in each patient. One example is olaparib in BRCA-mutated metastatic pancreatic cancer.

 

Testing for Microsatellite instability (MSI) immunotherapy biomarker is also included in this panel, and can expand the treatment opportunities with the FDA approved immunotherapy drug pembrolizumab for patients with MSI high status.

 

How many genes are tested in this panel?

26 genes

 

Recommendations by professional bodies

ESMO recommends liquid biopsy testing for patients with pancreatic cancer when tissue is not available (Pascual et al., 2022; ESMO recommendations).

 

References and more information: 

Information obtained from professional bodies including National Cancer Institute, World Cancer Research Fund International

Pascual J, Attard G, Bidard FC, Curigliano G, De Mattos-Arruda L, Diehn M, Italiano A, Lindberg J, Merker JD, Montagut C, Normanno N, Pantel K, Pentheroudakis G, Popat S, Reis-Filho JS, Tie J, Seoane J, Tarazona N, Yoshino T, Turner NC. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group. Ann Oncol. 2022 Aug;33(8):750-768. doi: 10.1016/j.annonc.2022.05.520. Epub 2022 Jul 6. PMID: 35809752.

Chi J, Chung SY, Prasad S, Saif MW. The Role of Olaparib in Metastatic Pancreatic Cancer. Cancer Med J. 2021 Dec;4(3):89-91. Epub 2021 May 11. PMID: 34151318; PMCID: PMC8208637.

GENES

ALK, ATM, BRAF, BRCA1, BRCA2, CDKN2A, CHEK2, ERBB2, FBXW7, FGFR1, FGFR2, FGFR3, KRAS, MLH1, MSH2, MSH6, MYC, NTRK1, NTRK2, NTRK3, PALB2, PMS2, ROS1, SMAD4, STK11, TP53
How to order

LATEST ARTICLES

Duchenne muscular dystrophy, a rare inherited muscle disorder characterized by progressive muscle weakness and degeneration that leads to difficultie...

Read more

May 12 is International Nurses Day. It is celebrated on Florence Nightingale’s birthday. She pioneered the field of modern nursing through her dedi...

Read more

Hair loss is a common problem that affects millions of men and women around the world. While genetics is believed to be the most significant factor c...

Read more

Depression is a serious mental health issue affecting over 280 million people worldwide. Recent research has revealed a potential link between gut he...

Read more

If you are unlucky enough to suffer from migraines, you will know that a migraine is not just a bad headache. The headache and accompanying symptoms ...

Read more

Autism spectrum disorder (ASD) is a neurological developmental disorder that affects brain development and function. This affects how people learn, b...

Read more

Researchers have developed a method called "Mendelian Phenotype Search Engine" (MPSE) to identify which sick infants in the neonatal intensive care u...

Read more

Did you know that wisdom teeth are actually an evolutionary leftover from our ancient ancestors that no longer serve their original purpose? These mo...

Read more

Azoospermia is a medical condition characterized by the absence of sperm in the ejaculate and is a major cause of male infertility. It affects 1 in 1...

Read more

Science has traditionally been a male dominated subject; however, women have also been hard at work in this field for decades. We put together this i...

Read more